Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 01, 2015

ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 28, 2017

    Lilly Loses Bid To Escape $20M Cialis Patent Verdict

    Eli Lilly & Co. on Friday lost a post-trial attempt to invalidate a German pharmaceutical company's patent when a Texas federal court denied a motion for judgment or a new trial, leaving Lilly to pay $20 million for infringing the patent when marketing the erectile dysfunction drug Cialis to treat enlarged prostates.

11 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login